American Journal of Medical Case Reports
ISSN (Print): 2374-2151 ISSN (Online): 2374-216X Website: http://www.sciepub.com/journal/ajmcr Editor-in-chief: Samy, I. McFarlane
Open Access
Journal Browser
Go
American Journal of Medical Case Reports. 2021, 9(3), 206-207
DOI: 10.12691/ajmcr-9-3-18
Open AccessLetter To Editor

A Rare Case of Combined Rocuronium Induced Malignant Hyperthermia and Propofol-Induced Lactic Acidosis

Mohamedanwar Ghandour1, , Heba Osman2, Samer Alkassis3, Zeenat Y. Bhat4 and Yahya Osman-Malik4

1Department of Internal Medicine, Nephrology division, Wayne State University/Detroit Medical Center, Michigan, USA

2Department of Internal Medicine/Pediatrics, Wayne State University/Detroit Medical Center, Michigan, USA

3Department of Internal Medicine, Wayne State University/Detroit Medical Center, Michigan, USA

4Department of Internal Medicine WSU SOM, Division of Nephrology Wayne State University, Michigan, USA

Pub. Date: January 14, 2021

Cite this paper:
Mohamedanwar Ghandour, Heba Osman, Samer Alkassis, Zeenat Y. Bhat and Yahya Osman-Malik. A Rare Case of Combined Rocuronium Induced Malignant Hyperthermia and Propofol-Induced Lactic Acidosis. American Journal of Medical Case Reports. 2021; 9(3):206-207. doi: 10.12691/ajmcr-9-3-18

Abstract

We report an unusual case of A 64-year-old female received rocuronium and propofol and subsequently developed malignant hyperthermia and particularly propofol-related infusion syndrome.

Keywords:

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Malignant hyperthermia: pathophysiology, clinical presentation, and treatment. AACN Clin Issues. 2004; 15: 231-7.
 
[2]  Nelson TE. Malignant hyperthermia: a pharmacogenetic disease of Ca++ regulating proteins. Curr Mol Med. 2002; 2: 347-69.
 
[3]  Maclennan DH, Zvaritch E. Mechanistic models for muscle diseases and disorders originating in the sarcoplasmic reticulum. Biochim Biophys Acta 2011; 1813:948.
 
[4]  Cully TR, Choi RH, Bjorksten AR, et al. Junctional membrane Ca2+ dynamics in human muscle fibers are altered by malignant hyperthermia causative RyR mutation. Proc Natl Acad Sci U S A 2018; 115: 8215.
 
[5]  Hatch DJ. Propofol-infusion in children. Lancet 1999; 353: 1117-8.
 
[6]  Van Straaten EA, Hendriks JJE, Ramsey G, Vos GD. Rhabdomyolysis and pulmonary hypertension in a child, possibly due to long-term high-dose propofol infusion. Intensive Care Medicine 1996; 22: 997.
 
[7]  Cremer OL, Moons KGM, Bouman EAC, Kruijswijk JE, De Smet AMGA, Kalkman CJ. Long term propofol infusion and cardiac failure in adult head-injured patients. Lancet 2001; 357: 117-8.
 
[8]  Perrier ND, Baerga-Varela Y, Murray MJ. Death related to propofol use in an adult patient. Critical Care Medicine 2000; 28: 3071-4.
 
[9]  Kam PCA, Cardone D. Propofol infusion syndrome. Anaesthesia. 2007; 62(7): 690-701.
 
[10]  Propofol (Diprivan) bivirkninger [Adverse effects of propofol (Diprivan)]. Ugeskr Laeger. 1990; 152(16): 1176.
 
[11]  Hemphill S, McMenamin L, Bellamy MC, Hopkins PM. Propofol infusion syndrome: a structured literature review and analysis of published case reports. Br J Anaesth. 2019; 122(4): 448-459.
 
[12]  Hemphill S, McMenamin L, Bellamy MC, Hopkins PM. Propofol infusion syndrome: a structured literature review and analysis of published case reports. British Journal of Anaesthesia. 2019; 122(4): 448-459.
 
[13]  Wappler F. Anesthesia for patients with a history of malignant hyperthermia. Curr Opin Anaesthesiol. 2010; 23: 417-22.
 
[14]  Rosero EB, Adesanya AO, Timaran CH et al. Trends and outcomes of malignant hyperthermia in the United States, 2000 to 2005. Anesthesiology. 2009; 110: 89-94.
 
[15]  Prabhu M, Samra S. An unusual cause of rhabdomyolysis following surgery in the prone position. J Neurosurg Anesthesiol. 2000; 12: 359-63.